Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2003
10/23/2003WO2002103060A3 Enterovirus nucleic acids and methods for detecting enterovirus
10/23/2003WO2002103041A3 Method and nucleic acids for the differentiation of prostate and renal carcinomas
10/23/2003WO2002099099A3 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
10/23/2003WO2002097061A3 Iterative promoter affinity chromatography to identify trans-regulatory networks of gene expression
10/23/2003WO2002094248A3 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample
10/23/2003WO2002092015A3 Reagents and methods for modulating dkk-mediated interactions
10/23/2003WO2002090583A3 Skin treatment
10/23/2003WO2002086159A3 Method for genotyping microsatellite dna markers
10/23/2003WO2002079479A3 Motor proteins and methods for their use
10/23/2003WO2002077216A3 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/23/2003WO2002077197A3 Methods for diagnosing and monitoring malignancies by screening gene copy numbers
10/23/2003WO2002072759A3 Method to screen peptide display libraries using minicell display
10/23/2003WO2002070730A3 Models and methods for determining systemic properties of regulated reaction networks
10/23/2003WO2002070556A9 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF
10/23/2003WO2002068589A3 Enzymes having alpha amylase activity and methods of use thereof
10/23/2003WO2002066989A3 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms
10/23/2003WO2002066494A8 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
10/23/2003WO2002063020A3 Soybean plants with enhanced yields and methods for breeding for and screening of soybean plants with enhanced yields
10/23/2003WO2002059358A3 Kit, method and microarray for determining predisposition towards osteoporosis
10/23/2003WO2002055700A3 Human genes and gene expression products isolated from human prostate
10/23/2003WO2002055536A3 Regulation of target protein activity through modifier proteins
10/23/2003WO2002048404A3 Method and kit for enhancing the association rates of polynucleotides
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2002044321A3 Rna interference mediating small rna molecules
10/23/2003WO2002038811A3 Assay for the detection and quantitation of hemimethylation
10/23/2003WO2002036813A3 Detection of rare candida species
10/23/2003WO2002029007A3 Bacteria used for oxidising arsenic, method for selecting same and uses thereof for treating media containing arsenic
10/23/2003WO2002028507A3 Electronic detection of interaction based on the interruption of flow
10/23/2003WO2002024745A3 Method for detecting tumor cells
10/23/2003WO2002020838A3 Method and system for detecting nucleic acids
10/23/2003WO2002010447A3 Method for detecting nucleic acids by means of hybridization, use of this method and corresponding analysis kit and nucleic acid oligomers and use thereof
10/23/2003WO2002010438A3 Serial analysis of transcript expression using long tags
10/23/2003WO2001096376A9 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
10/23/2003WO2001068805A3 Human olfactory receptors and genes encoding same
10/23/2003WO2001055337A9 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/23/2003WO2001040519A8 Methods for identifying modulators for balance related disorders
10/23/2003WO2001027635A8 Multiwell scanner and scanning method
10/23/2003WO2001025474A8 Sensor for measuring a bioanalyte such as lactate
10/23/2003WO2001009711A8 Methodology for identifying plants and other organisms having traits differing from a normal population
10/23/2003WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003WO2001000879A8 Novel kinases and uses thereof
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
10/23/2003WO2001000811A8 17867, a novel human aminopeptidase
10/23/2003US20030200569 Amino acid:glyoxylate aminotransferase genes from plants and uses thereof
10/23/2003US20030200555 For Alzheimer's disease diagnosis, treatment
10/23/2003US20030199837 Anti-inflammatory biosensor for reduced biofouling and enhanced sensor performance
10/23/2003US20030199685 Detects changes in the level and pattern of expression of the molecular markers in the cell- based sample
10/23/2003US20030199472 Administering to the patient an effective amount of an expression construct comprising nucleic acid comprising a sequence encoding a modified estrogen receptor, wherein sequence is under control of promoter
10/23/2003US20030199470 Determining the status of 158P1D7 gene products expressed by cells in a tissue sample; comparing the status so determined to the status of 158P1D7 gene products in normal sample; identifying the presence of aberrant 158P1D7 gene products
10/23/2003US20030199468 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences
10/23/2003US20030199467 Antisense modulation of human Rho family gene expression
10/23/2003US20030199464 Regeneration of endogenous myocardial tissue by induction of neovascularization
10/23/2003US20030199463 For therapy of cardiovascular disease, fibrotic disease
10/23/2003US20030199437 Identification, isolation and recombinant production of novel DNA; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules; fused heterologous polypeptide sequences, binding antibodies; anticarcinogenic
10/23/2003US20030199435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199428 Identifying a thrombin generation time for a blood sample to assess risk of bleeding, to diagnose various disorders, and to monitor the effects of pharmaceutical and other treatments.
10/23/2003US20030199423 ICAM-related protein
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199097 Measurements for a sample on the measuring surfaces of a substrate which makes it possible to simplify the control and construction of a measuring device, shorten the measuring period, make the measuring conditions constant with accuracy
10/23/2003US20030199081 Utilized to implement a polymerase chain reaction (PCR); contains sample polynucletide, polymerase, nucleoside triphosphates, primers, and a temperature controller for controlling temperature of contents of chamber;
10/23/2003US20030199078 Lysing a biological sample containing an analyte in a reaction vessel, adding a solid adsorption matrix, incubating to bind analyte to the adsorption matrix, removing non-bound components, incubating to elute analyte from the matrix
10/23/2003US20030199064 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199063 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199062 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199061 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199060 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199059 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199058 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199057 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199056 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199054 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199053 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199052 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199051 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199044 IL-17 homologous polypeptides and therapeutic uses thereof
10/23/2003US20030199036 Ubiquitin ligases, and uses related thereto
10/23/2003US20030199033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199032 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199031 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199030 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199029 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199028 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199027 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199026 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199025 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199023 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199018 Filtering material, having ionic copper Cu+ or Cu++ ions incorporated therein for inactivating HIV contained in fluid brought in contact, followed by a layer of activated charcoal for removal of copper ions; used to filter blood and milk
10/23/2003US20030199017 Method for releasing a product comprising chemical oxidation, method for detecting said product and uses thereof
10/23/2003US20030199016 Incubating the sample with a protease capable of cleaving theArg275-Ile276 bond of human wild-type tPA (plasmogen activator) and then with denaturing/reducing agents to reduce the disulfide bonds of tPA, performing reverse phase HPLC
10/23/2003US20030199015 Reacting a sample obtained from a patient with a thiopurine derivative free of 6-mercaptopurine, contacting with perchloric acid, precipitating proteinaceous material from the sample, separating, detecting methylated purine product
10/23/2003US20030199014 Addition of low levels of divalent metal ions or monovalent copper ion, together with calcium ions, enhance the anticoagulant activity of the Protein C anticoagulant patheway
10/23/2003US20030199012 A nucleic acid construct having a nucleic acid molecule that encodes a factor suppressing an immune response to Mycobacterium tuberculosis in a host cell
10/23/2003US20030199008 Nucleic Acids, Proteins, and antibodies
10/23/2003US20030199002 For the treatment, management, or prevention of disorders associated with abnormal expression and/ or activity of clk-2 (clock-2) nucleic acids; treating or preventing disorders associated with decreased/increased apoptosis e.g. cancer
10/23/2003US20030198994 Identification and isolation of novel DNA and the recombinant production of novel polypeptides encoded by that DNA
10/23/2003US20030198989 For use as a diagnostic reagent for detecting the presence or absence of a target molecule in a sample; Systematic Evolution of Ligands by EXponential enrichment (SELEX)
10/23/2003US20030198988 Optimization of crossover points for directed evolution
10/23/2003US20030198987 Methods for designing oligo-probes with high hybridization efficiency and high antisense activity